<DOC>
	<DOCNO>NCT00295178</DOCNO>
	<brief_summary>This study design investigate difference speed degree symptom resolution daptomycin vancomycin subject treat cellulitis erysipelas evaluation follow parameter : - Time erythema margin cessation progress - Time defervescence - Time hospital discharge follow relief present cellulitis erysipelas - Degree improvement follow sign symptom cellulitis erysipelas include - Degree improvement cellulitis-related pain swell report subject Additionally , difference frequency Adverse Events daptomycin vancomycin describe .</brief_summary>
	<brief_title>Study Comparing CUBICIN® ( Daptomycin Injection ) With Vancomycin Cellulitis Erysipelas</brief_title>
	<detailed_description />
	<mesh_term>Cellulitis</mesh_term>
	<mesh_term>Erysipelas</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>1 . Read sign informed consent form nature study fully explain ; 2 . Male female &gt; = 18 year age ; 3 . If female childbearing potential , negative pregnancy test require ; 4 . Primary diagnosis cellulitis/ erysipelas 1. onset sign symptom within 3 day 1st dose study medication 2. require hospitalization , severe enough warrant IV antibiotic 3. temperature &gt; 37.5°C ( 99.5° F ) oral &gt; 38° C ( 100.2° F ) rectal , document within 48 hour prior enrollment , 4. anticipate treatment limited medical ( NOT surgical ) intervention 5. anatomical location allow clear assessment erythema margin 1 . Pregnant lactate female ; 2 . Conditions require surgery ( ) constitute curative treatment infection removal infect site ( e.g. , amputation ) ; 3 . Conditions require emergent surgical intervention site infection ( e.g. , progressive necrotizing infection ) ; 4 . Previous systemic antimicrobial therapy exceed 24 hour duration , administer anytime 72 hour prior first dose study drug unless previous antibiotic least 72 hour without clinical improvement ; 5 . Cellulitis associate wound infection ulcer require incision drainage debridement 6 . Perirectal abscess hidradenitis suppurativa third degree burn infection 7 . Buccal cellulitis , facial cellulitis , perianal cellulitis , periorbital cellulitis ; 8 . Known suspected osteomyelitis , pneumonia , bacteremia , endocarditis , urinary tract infection ; 9 . Known allergic intolerant study medication ; 10 . Subjects Creatinine Clearance ( CLCR ) &lt; 30 mL/min ; 11 . Requirement nonstudy systemic antibiotic ; 12 . Requirement systemic steroid enrollment stabilization cellulitis ; 13 . Rhabdomyolysis ; 14 . Neutropenic subject absolute neutrophil count ≤ 500 cells/mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>